Franklin Resources
MAZE

Franklin Resources’s Maze Therapeutics MAZE Stock Holding History

Franklin Resources’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Buy
59,637
+4,408
+8% +$195K ﹤0.01% 1948
2025
Q4 		$2.29M Buy
55,229
+37,031
+203% +$1.27M ﹤0.01% 1722
2025
Q3 		$472K Buy
+18,198
New +$307K ﹤0.01% 2454

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Franklin Resources's MAZE Position: Q1 2026 in Review

Franklin Resources increased its Maze Therapeutics (MAZE) stake by 8% in Q1 2026, buying an estimated $195K and bringing the position to 59,637 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1948.

Franklin Resources first reported a position in MAZE in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.29M in Q4 2025. 165 funds tracked by Wall St. Rank hold MAZE as of Q1 2026.

  • Franklin Resources held 59,637 shares of Maze Therapeutics worth $1.78M as of Q1 2026.
  • Franklin Resources bought 4,408 Maze Therapeutics shares in Q1 2026, an estimated $195K.
  • Maze Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1948 holding.
  • Franklin Resources first reported a position in Maze Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Franklin Resources's Maze Therapeutics position peaked at $2.29M in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Maze Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.